ABBV19:BKK
Abbvie Yuanta DR
THB 8.80
arrow_downward
-1.68%(-0.15) 1D
Sep 29, 9:25:39 PM GMT+7 · THB
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV19...
Open
THB 8.90
High
THB 9.00
Low
THB 8.90
Mkt. cap
463.76B
Avg. vol.
58.97K
Volume
3.68K
52-wk high
THB 9.00
52-wk low
THB 6.25
Shares outstanding
1.77B
No. of employees
57K
Open
THB 8.90
High
THB 9.00
Low
THB 8.90
Mkt. cap
463.76B
Avg. vol.
58.97K
Volume
3.68K
52-wk high
THB 9.00
52-wk low
THB 6.25
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
Benzinga
·
19 minutes ago
UnitedHealth, AbbVie And A Health Care Stock On CNBC’s ‘Final Trades’
Zacks Investment Research
·
18 hours ago
Top Research Reports for Alphabet, Mastercard & AbbVie
Investing.com
·
20 hours ago
AbbVie gets FDA approval for Parkinson’s disease drug Juvmo
Traders Union
·
1 day ago
AbbVie shares weekly forecast: recovery holds but faces a stretched setup
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About Abbvie Yuanta DR
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com